Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 2/2008

01-04-2008 | Letter

Saccharomyces boulardiifungaemia in an intensive care unit patient treated with caspofungin

Authors: Nikolaos Lolis, Dimitrios Veldekis, Hellen Moraitou, Sofia Kanavaki, Aristea Velegraki, Charis Triandafyllidis, Chronis Tasioudis, Angellos Pefanis, Ioannis Pneumatikos

Published in: Critical Care | Issue 2/2008

Login to get access

Abstract

We describe a case of Saccharomyces boulardii fugaemia in a critically ill patient with septic shock treated with a probiotic agent containing this yeast. We attributed this fugaemia to gut translocation. Our use of caspofugin yielded excellent results.
Literature
1.
Czeruckat D, Piche P, Rampal P: Review article: yeast as probiotics – Saccharomyces boulardii. Aliment Pharmacol Ther. 2007, 26: 767-778.CrossRef
2.
Bleichner G, Blehaut H, Mentec H, Moyse D: Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med. 1997, 23: 517-523. 10.1007/s001340050367.PubMedCrossRef
3.
Lherm T, Monet C, Nougière B, Soulier M, Larbi D, Le Gall C, Caen D, Malbrunot C: Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 2002, 28: 797-801. 10.1007/s00134-002-1267-9.PubMedCrossRef
4.
Basseti S, Frei R, Zimmerli W: Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am J Med. 1998, 105: 71-72. 10.1016/S0002-9343(98)00133-8.CrossRef
Metadata
Title
Saccharomyces boulardiifungaemia in an intensive care unit patient treated with caspofungin
Authors
Nikolaos Lolis
Dimitrios Veldekis
Hellen Moraitou
Sofia Kanavaki
Aristea Velegraki
Charis Triandafyllidis
Chronis Tasioudis
Angellos Pefanis
Ioannis Pneumatikos
Publication date
01-04-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc6843

Other articles of this Issue 2/2008

Critical Care 2/2008 Go to the issue

Letter

Prehospital therapeutic hypothermia in cardiac arrest: will there ever be evidence?

Commentary

Pulmonary artery occlusion pressure estimation by transesophageal echocardiography: is simpler better?

Research

Introduction of Medical Emergency Teams in Australia and New Zealand: a multi-centre study

Research

Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats

Commentary

Vasopressin in vasodilatory shock: is the heart in danger?

Review

Clinical review: Airway hygiene in the intensive care unit